How Do I Monitor Competitor Recalls for PMS? 4-Level Guide (2026)

Level 1 — Explain It Like I'm Five

If another kid's toy car breaks and hurts someone, and your toy car uses the same kind of wheels, shouldn't you check your car too? Of course!

That's what competitor recall monitoring is. When a similar device gets recalled, you check whether your device has the same problem. Not because someone told you to, but because it's the smart thing to do — and because regulators expect it.

Level 2 — The General Picture

Monitoring competitor recalls means systematically tracking regulatory actions on devices that are similar to yours — same intended purpose, same technology, same product codes. When a competitor recalls a device for a specific failure mode, you must evaluate whether that failure mode could also affect your device.

Why is it required?

EU MDR Article 84 explicitly requires monitoring "similar devices on the market." FDA expects you to be aware of adverse events and recalls on predicate devices. MDSAP auditors verify that you have a systematic process for similar-device monitoring. A competitor recall for a failure mode that also applies to your device — and you didn't know about it — is a major audit finding.

Level 3 — Exactly How to Do It

Step 1: Define "similar devices"

• Same intended purpose (e.g., patient monitoring, orthopedic fixation, wound closure)
• Same technology platform (e.g., lithium-ion battery, nitinol, silicone)
• Same FDA product codes or EU EMDN codes
• Your predicate devices (510(k) predicates)
• Devices from your direct competitors

Step 2: Choose your monitoring sources

Step 3: Evaluate each signal

For every competitor recall you identify, document your evaluation:

1. Is the failure mode relevant to our device? — Same technology, same component, same use environment?
2. Do we use the same supplier or material? — Shared supply chain creates shared risk
3. Have we seen similar complaints? — Cross-reference against your internal complaint data
4. Is action needed? — Update risk file, open CAPA, update labeling, inform users?
5. Document the conclusion — Even if the answer is "not applicable to our device," write it down with your rationale

Step 4: The practical solution

Manual monitoring of 7+ regulatory databases weekly is unsustainable for most teams. TrueMedDevice solves this by aggregating 548,000+ records from FDA and Health Canada databases, matching them against your device profiles, and delivering pre-screened alerts with relevance scoring. Each alert includes a rationale for why it's relevant — ready for your review, override, and inclusion in your inspection-ready evidence pack.

Level 4 — The Deeper Analysis

The information asymmetry problem

Competitor recall monitoring creates an information asymmetry: public databases contain only what manufacturers and authorities publish. FDA's MAUDE database is passive surveillance with known underreporting. EU vigilance data is fragmented across national competent authorities (EUDAMED vigilance module isn't fully operational yet). This means the absence of competitor recalls doesn't equal absence of problems — it may just mean problems haven't been reported or made public yet.

The regulatory expectation vs. reality gap

EU MDR Article 84 and MDCG 2025-10 require "proactive and systematic" monitoring of similar devices. Yet most small/medium manufacturers check FDA recalls "when they remember" — quarterly at best, often not at all. This is the most common external PMS gap identified in MDSAP audits. The gap exists because manual database monitoring is time-consuming, inconsistent, and hard to audit. Automated platforms close this gap by making monitoring continuous, documented, and auditable.

Turning competitor intelligence into competitive advantage

Smart RA/QA teams don't just monitor for compliance — they use competitor recall data strategically. A competitor's recall for a battery overheating issue tells you: (1) FDA is focused on this failure mode, (2) inspectors may ask you about it, (3) your investors/customers may ask about it. Proactively addressing the same risk in your device — updating your risk file, running additional testing, publishing a safety communication — positions you as the safer choice in procurement decisions.